Abstract
Aim — Background
Barrett’s oesophagus is a condition caused by acid reflux from the stomach to the oesophagus for a prolonged period of time. Patients with Barrett’s oesophagus are at significant risk of developing oesophageal adenocarcinoma. This risk decreases with antireflux surgery. Treatment of gastroesophageal reflux disease (GERD) by Nissen fundoplication surgery has a success rate of 85–90%. The aim of this study is to highlight the significance of oesophageal pH measurement as part of the postoperative follow-up of patients diagnosed with Barrett’s oesophagus who undergo the Nissen fundoplication procedure.
Patients and methods
Between 2010 and 2012, eleven patients with Barrett’s oesophagus underwent Nissen fundoplication in our clinic, followed by 48h wireless oesophageal pH-metry monitoring.
Results
All patients reported relief of GERD typical symptoms. Mean DeMeester score of 1.5 was measured at the fifth postoperative month.
Conclusion
Prevention of oesophageal adenocarcinoma in patients with Barrett’s oesophagus is crucial. These patients are exposed to a great risk of adenocarcinoma development, not only owing to the potential progression of Barrett’s oesophagus to adenocarcinoma, but also because of the decreased capacity to experience typical GERD symptoms. Given the possibility of antireflux surgery failure and the fact that symptoms may be an unreliable indicator of GERD presence, postoperative oesophageal pHmetry is mandatory.
Similar content being viewed by others
References
Proximal and distal esophageal sensitivity is decreased in patients with Barrett’s esophagus. Krarup AL, Olesen SS, Funch-Jensen P, Gregersen H, Drewes AM. World J Gastroenterol. 2011 Jan 28;17(4):514–521. doi: 10.3748/wjg.v17.i4.514. PMID: 21274382[PubMed — indexed for MEDLINE]Free PMC Article
Surveillance for Barrett’s oesophagus: worthwhile. Kastelein F, Kuipers EJ. Ned Tijdschr Geneeskd. 2012;156(49):A5497. Dutch.PMID: 23218039 [PubMed — in process]
Review on the Annual Cancer Risk of Barrett’s Esophagus in Persons with Symptoms of Gastroesophageal Reflux Disease. Lenglinger J, Riegler M, Cosentini E, Asari R, Mesteri I, Wrba F, Schoppmann SF. Anticancer Res. 2012 Dec;32(12):5465–5473. PMID:23225453[PubMed — in process]
The effects of laparoscopic Nissen fundoplication onBarrett’sesophagus:long-termresults. Simonka Z Paszt A, Abraham S, Pieler J, Tajti J, Tiszlavicz L, Németh I, Izbéki F, Rosztoczy A, Wittmann T, Rarosi F, Lazar G. Scand J Gastroenterol. 2012 Jan;47(1):13–21. doi: 10.3109/00365521.2011.639081. Epub 2011 Dec 8.PMID:22150083[PubMed — indexed for MEDLINE]
Histologic and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett’s esophagus. Ozmen V, Oran ES, Gorgun E, Asoglu O, Igci A, Kecer M, Dizdaroglu F. Surg Endosc. 2006 Feb;20(2):226–229. Epub 2005 Dec 9.PMID:16362470[PubMed — indexed for MEDLINE]
Influence of wrap length on the effectiveness of Nissen and Toupet fundoplications: 5-year results of prospective, randomized study. Mickevicius A, Endzinas Z, Kiudelis M, Jonaitis L, Kupcinskas L, Pundzius J, Maleckas A. Surg Endosc. 2012 Oct 6. [Epub ahead of print]PMID:23052526[PubMed — as supplied by publisher]
Relationship between symptom response and oesophageal acid exposure after medical and surgical treatmentfor gastro-oesophageal reflux disease. Jenkinson AD, Kadirkamanathan SS, Scott SM, Yazaki E, Evans DF. Br J Surg. 2004 Nov;91(11):1460–1465.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsagaropoulos, N., Doulami, G., Kokoroskos, N. et al. Barrett’s oesophagus and nissen fundoplication. The significance of postoperative oesophageal pH measurement. Hellenic J Surg 85, 185–188 (2013). https://doi.org/10.1007/s13126-013-0034-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13126-013-0034-4